8-K
filed June 23, 2023, 7:59 PM ET
ticker ALLR
CIK 0001860657
other material
confidence high
sentiment neutral
materiality 0.60
Allarity Therapeutics stockholders approve reverse stock split of up to 1-for-50
Allarity Therapeutics, Inc.
- Shareholders approved reverse stock split at ratio between 1-for-15 and 1-for-50, ratio set by Board with Series A consent.
- Reverse stock split proposal received 24,984,901 votes for, 7,906,612 against, and 40,629 abstentions.
- Adjournment proposal approved with 27,928,931 votes for, 4,899,237 against, and 103,974 abstentions.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Allarity Therapeutics, Inc. shareholders approved To approve the adjournment of the meeting, if necessary or advisable, to solicit additional proxies in favor of the Reverse Stock Split Proposal at the 2023-06-23 meeting.
- Proposal
- reverse split
- Outcome
- passed
- Meeting
- 2023-06-23
Exact text from the filing
Proposal 2 : To approve the adjournment of the meeting, if necessary or advisable, to solicit additional proxies in favor of the Reverse Stock Split Proposal (“Adjournment Proposal”). Votes For Votes Against Abstentions Broker Non-Votes 27,928,931 4,899,237 103,974 -
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Allarity Therapeutics, Inc. shareholders approved To approve an amendment to our Certificate of Incorporation to effect a reverse stock split at a ratio between 1-for-15 and 1-for-50 at the 2023-06-23 meeting.
- Proposal
- reverse split
- Outcome
- passed
- Meeting
- 2023-06-23
Exact text from the filing
Proposal 1 : To approve an amendment to our Certificate of Incorporation, as amended, in substantially the form attached to the Proxy Statement as Appendix A, to, at the discretion of the Board of Directors of the Company (the “Board”), effect a reverse stock split with respect to the Company’s issued and outstanding common stock, par value $0.0001 per share, at a ratio between 1-for-15 and 1-for-50 (the “Range”), with the ratio within such Range to be determined at the discretion of the Board, subject to the consent of the holder of Series A Preferred Stock (the “Reverse Stock Split Proposal”) and included in a public announcement. Votes For Votes Against Abstentions Broker Non-Votes 24,984,901 7,906,612 40,629 -
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.